Yearly Archives: 2023

/2023

MHRA Class 2 Medicines Recall: Sabril 500 mg film-coated tablets & 500 mg granules for oral solution (Aventis Pharma Limited (t/a Sanofi))

Drug alert number: EL (23)A/25 Date issued: 10 July 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Sabril 500 mg film-coated tablets & Sabril 500 mg granules for oral solution (Aventis Pharma Limited (t/a Sanofi)) Product name Sabril 500 mg film-coated tablets, PL 04425/0171 Batch number [...]

The post MHRA Class 2 Medicines Recall: Sabril 500 mg film-coated tablets & 500 mg granules for oral solution (Aventis Pharma Limited (t/a Sanofi)) appeared first on Community Pharmacy England.

By |July 13th, 2023|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Sabril 500 mg film-coated tablets & 500 mg granules for oral solution (Aventis Pharma Limited (t/a Sanofi))

MHRA Class 2 Medicines Recall: Sabril 500mg film-coated tablets and 500mg granules for oral solution (Aventis Pharma Limited (t/a Sanofi)

Date issued: 13 July 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Sabril 500 mg film-coated tablets & Sabril 500 mg granules for oral solution. Sabril 500 mg film-coated tablets Pl 04425/0171 Batch number Expiry date Pack size First distributed 2989A April 2025 100 02/08/22 2988D [...]

The post MHRA Class 2 Medicines Recall: Sabril 500mg film-coated tablets and 500mg granules for oral solution (Aventis Pharma Limited (t/a Sanofi) appeared first on Community Pharmacy England.

By |July 13th, 2023|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Sabril 500mg film-coated tablets and 500mg granules for oral solution (Aventis Pharma Limited (t/a Sanofi)

July 2023 Price Concessions 1st Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners (our members), the Department has today (13/07/2023) announced the following initial list of price concessions for July 2023: Drug Pack size Price concession Amisulpride 100mg tablets 60 £18.15 Atorvastatin 10mg tablets 28 [...]

The post July 2023 Price Concessions 1st Update appeared first on Community Pharmacy England.

By |July 13th, 2023|Lexpos News|Comments Off on July 2023 Price Concessions 1st Update

Class 4 Medicines Defect Information: Cipla (UK) Limited and Pharmathen S.A – Various Products

Class 4 Medicines Defect Information: Cipla (UK) Limited and Pharmathen S.A – Various Products Drug alert number:EL (23)A/24 Date issued: 13 July 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Cipla (UK) Limited and Pharmathen S.A – Various Products Company name: Cipla (EU) Limited, [...]

The post Class 4 Medicines Defect Information: Cipla (UK) Limited and Pharmathen S.A – Various Products appeared first on Community Pharmacy England.

By |July 13th, 2023|Lexpos News|Comments Off on Class 4 Medicines Defect Information: Cipla (UK) Limited and Pharmathen S.A – Various Products

Community Pharmacy England briefs MPs on medicines supply issues

Community Pharmacy England has been in Parliament today alongside patient representatives and others to highlight our ongoing concerns about medicines supply to MPs. Medicines supply remains a critical issue for community pharmacies with disruption causing problems both accessing medicines and procuring them cost effectively. In our recent sector polling, community pharmacy owners rated medicines supply [...]

The post Community Pharmacy England briefs MPs on medicines supply issues appeared first on Community Pharmacy England.

By |July 10th, 2023|Lexpos News|Comments Off on Community Pharmacy England briefs MPs on medicines supply issues